Tramadol Hcl Tablet, Extended Release
Product Images NDC 80425-0312

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Tramadol Hcl (NDC 80425-0312). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Advanced Rx Pharmacy Of Tennessee, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Fig 1 (Fig 1)

The text describes a chart showing the concentration of Tramadol, a medication used to relieve moderate to severe pain, in ng/mL over time. Two types of tablets are compared: Tramadol Hydrochloride Extended-Release Tablets (200 mg q.d) and Tramadol Hydrochloride Tablets (50 mg g6h). The chart displays concentrations ranging from 50 ng/mL to 350 ng/mL and times ranging from 0 to 24 hours.*

FDA Label Image

Fig 2 (Fig 2)

There is a graph showing the concentration of M1 over time in hours. Two types of tablets are compared, 200 mg q.d. extended-release tablets and 50 mg g6h tablets, both containing Tramadol Hydrochloride. The concentration of M1 is shown in ng/mL and varies from 20 to 120 ng/mL.*

FDA Label Image

Fig 3 (Fig 3)

This is a graph showing the percentage of patients who achieved different levels of pain response while taking Tramadol Hydrochloride Extended-Release Tablets during Study 023 WOMAC Pain Responder Analysis. The graph compares the effectiveness of different dosages of Tramadol Hydrochloride Extended-Release Tablets (100 mg, 200 mg, 300 mg, and 400 mg) with a placebo group. The x-axis indicates the percentage of improvement from baseline pain levels, while the y-axis shows the percentage of patients achieving each level of improvement.*

FDA Label Image

Fig 4 (Fig 4)

The text describes a graph that shows the percentage of patients achieving response to Tramadol Hydrochloride Extended-Release Tablets Study 015 for Arthritis Pain Intensity. The graph shows the response threshold percentages from the baseline in increasing order on the x-axis, and the percentage of patients achieving responses on the y-axis. The graph compares the results of patients taking the Tramadol Hydrochloride Extended-Release Tablets to those who took a placebo.*

FDA Label Image

Structure (Structure)

FDA Label Image

Label 1 (Tramadol 300mg 80425 0312 01)

The text is a mix of information about a location (temperature) and a prescription medication (Tramadol 300mg Tablet ER). It includes details such as the lot number, expiration date, and source code. The could not decipher the meaning of "IR0<" or "SoiE N catmo sase-0n S/N: 000000138264".*

FDA Label Image

Label 2 (Tramadol 300mg 80425 0312 02)

This is a prescription of 60 tablets of Tramadol 300mg extended-release, with NDC 0325-0312-02 and source NDC 68180-0999-06. The expiration date is 8731/3025 and the serial number is 000000138269.*

FDA Label Image

Label 3 (Tramadol 300mg 80425 0312 03)

The description of the medication is as follows: Tramadol 300mg extended-release tablet with 90 tablets in the bottle. The NDC number for the medication is 68180-0699-06 with a lot number of XXXHXX and expiry date of 8/31/2025. The text also includes a reference to another medication called "ANAACOL" and a serial number of 000000130272, but no additional details are provided.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.